Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | CEO, Director | $10.4M | +$209K | +2.05% | Jun 30, 2024 |
GKOS | GLAUKOS Corp | Director | $4.06M | -$423K | -9.45% | May 30, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|